Popular topics to explore
NEULANDLAB
reported a strong performance in its consolidated Q4 FY26 results, with net profit surging nearly eight times to Rs 212.7 crore compared to Rs 27.8 crore in the year-ago quarter. Revenue also jumped 136.4% year-on-year to Rs 776.3 crore from Rs 328.4 crore, reflecting robust business growth and improved operational performance. Following the earnings announcement, the stock opened sharply higher with a 7.6% gap-up rally. However, profit booking emerged during the session, eroding the initial gains. As of 12:25 PM on May 13, 2026, the stock was trading around 2% lower from its intraday high levels.
Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.#StockInNews#WatchOutFor#FundamentalViews
1,189 likes·87 comments

















